CYTK

Cytokinetics’ (CYTK) CEO Robert Blum on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Robert I. Blum Thank you, Sharon and thank you to everyone on the line for joining us for this call today. The first quarter of 2014 was an important one for Cytokinetics, but that does not diminish our … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee […]

Cytokinetics, Incorporated Reports First Quarter 2014 Financial Results

[Thomson Reuters ONE] – Company Considers Potential Next Steps for First-in-Class Skeletal Muscle Activator Focused to ALS Partnered and Funded Programs Advancing Through Clinical Trials in Parallel SOUTH SAN FRANCISCO, CA, May … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee who Cytokinetics is hiring next, click here to view […]

ShawCor’s CEO Presents at Investor Breakfast and Webcast Following Presentation of Results from BENEFIT-ALS Conference (Transcript)

[at Seeking Alpha] – We’ll then open up the program for questions and answers from all of you. I’ll make then a few concluding remarks. Here are the people that will be on the panel. I’ve described them as they’re also now … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee […]